Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 6, 2005
Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry
Suresh K Balani, Nelamangala V Nagaraja, Mark G Qian, et al.
Genetics and Molecular Research : GMR
|
January 20, 2016
Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer
Y Yu, F Lv, H Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target
Ami V Patel, David Eaves, Walter J Jessen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
June 18, 2025
[The impact of myocardial infarct size dynamics on left ventricular remodeling in STEMI patients after primary percutaneous coronary intervention]
S Chen, X A, Y Q Zhao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
October 15, 2020
[3D-imaging assisted surgery planning in patients with recurrent colon cancer]
Y Hu, F Z Han, B S Zhao, et al.
Molecular Cancer Therapeutics
|
May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models
Mari Kogiso, Lin Qi, Frank K Braun, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts
Adnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.
Journal of Medicinal Chemistry
|
November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)
Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 6, 2005
Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry
Suresh K Balani, Nelamangala V Nagaraja, Mark G Qian, et al.
Genetics and Molecular Research : GMR
|
January 20, 2016
Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer
Y Yu, F Lv, H Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target
Ami V Patel, David Eaves, Walter J Jessen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
June 18, 2025
[The impact of myocardial infarct size dynamics on left ventricular remodeling in STEMI patients after primary percutaneous coronary intervention]
S Chen, X A, Y Q Zhao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
October 15, 2020
[3D-imaging assisted surgery planning in patients with recurrent colon cancer]
Y Hu, F Z Han, B S Zhao, et al.
Molecular Cancer Therapeutics
|
May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models
Mari Kogiso, Lin Qi, Frank K Braun, et al.
Molecular Cancer Therapeutics
|
August 14, 2020
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts
Adnan O Abu-Yousif, Donna Cvet, Melissa Gallery, et al.
Journal of Medicinal Chemistry
|
November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)
Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Page
of 16